This site is intended for health professionals only

At the heart of general practice since 1960

Inhaled insulin effective long-term

Inhaled insulin maintains glycaemic control and pulmonary function in patients with diabetes even over four years of continuous therapy, according to new research.

A University of Miami study found the rate of overall hypoglycaemia decreased from 2.58 episodes/subject month to 1.50 after four years of treatment using inhaled insulin.

The study looked at 204 patients with type 1 diabetes, insulin-treated type 2 diabetes or type 2 diabetes who had taken part in three month randomised clinical trials for inhaled insulin.

Mean HbA1c was 8.23 after four years in inhaled insulin patients compared with 8.71 at the start of the treatment.

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say